文献速递腹部技术与安全CTMR

比较简化钆塞酸增强MRI与增强CT用于结直肠癌肝转移术后监测的个体内研究:一项多中心前瞻性研究

Intra-individual comparison of abbreviated gadoxetic acid-enhanced MRI and contrast-enhanced CT for postoperative surveillance of colorectal liver metastases: a multicenter prospective study.
PubMed 文献 · Abdom Radiol (NY) · 2025-11-04

这项多中心前瞻性研究纳入462例结直肠癌患者,在24个月监测期内每6个月配对进行增强CT和简化肝胆期MRI(HBP-AMRI,总采集时间优化至5分钟)。HBP-AMRI在全部及亚厘米病灶检出率、患者水平特异度(94.35% vs 86.92%)、准确率(94.04% vs 86.23%)和敏感度(90.35% vs 78.07%)方面均优于增强CT。

要点

  • HBP-AMRI在全部及亚厘米病灶检出率上均显著高于增强CT(所有P < 0.05)。
  • 24个月汇总数据显示HBP-AMRI特异度94.35% vs 增强CT 86.92%,准确率94.04% vs 86.23%。
  • HBP-AMRI敏感度90.35% vs 增强CT 78.07%,阴性预测值99.14% vs 97.91%,阳性预测值57.54% vs 33.59%。

核心结论

  • 采用5分钟简化流程的HBP-AMRI在结直肠癌肝转移病灶检出率和患者水平诊断性能上显著优于增强CT,可作为结直肠癌患者结直肠癌肝转移术后监测的高效、安全且具有纵向可靠性的替代检查方式。

研究设计与样本

  • 多中心前瞻性研究,纳入462例结直肠癌患者,在24个月监测期内每6个月配对进行增强CT和HBP-AMRI检查;HBP-AMRI方案包括T2加权成像、扩散加权成像和注射后10分钟肝胆期成像,总采集时间优化至5分钟。

诊断标准与关键数值

  • HBP-AMRI较增强CT的24个月汇总患者水平诊断性能:敏感度90.35% vs 78.07%(P = 0.023),特异度94.35% vs 86.92%(P < 0.001),准确率94.04% vs 86.23%(P < 0.001),阴性预测值99.14% vs 97.91%,阳性预测值57.54% vs 33.59%。

临床应用与阅片要点

  • 在结直肠癌肝转移术后监测中,HBP-AMRI对全部及亚厘米病灶的检出率在各监测轮次均显著高于增强CT(所有P < 0.05),且患者水平特异度、准确率、敏感度、阴性预测值和阳性预测值均更优,可提供纵向可靠的监测结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To intra-individually compare the diagnostic performance of hepatobiliary phase (HBP)-abbreviated MRI (AMRI) and contrast-enhanced CT (CE-CT) in postoperative surveillance of colorectal liver metastases (CRLMs).

METHODS: This multicenter prospective study enrolled 462 patients with colorectal cancer who underwent paired CE-CT and HBP-AMRI every six months over a 24-month surveillance period. The HBP-AMRI protocol comprised T2-weighted imaging, diffusion-weighted imaging, and HBP at 10 min post-injection, with total acquisition optimized to 5 min. Lesion detection rates for all and subcentimeter lesions, and patient-level sensitivity, specificity, and accuracy were compared between CE-CT and HBP-AMRI by McNemar χ2 test. Receiver operating characteristic (ROC) curves were constructed across all surveillance intervals.

RESULTS: HBP-AMRI demonstrated significantly higher detection rates than CE-CT across all surveillance rounds for all and subcentimeter lesions (all P < 0.05). The pooled 24-month data demonstrated HBP-AMRI significantly outperformed CE-CT in specificity (overall: 94.35% vs. 86.92%; P < 0.001), and accuracy (overall: 94.04% vs. 86.23%; P < 0.001). A consistent trend was observed across each individual surveillance round. The pooled 24-month analysis revealed HBP-AMRI had significantly higher sensitivity than CE-CT (overall: 90.35% vs. 78.07%; P = 0.023). HBP-AMRI maintained a superior negative predictive value (NPV) compared with CE-CT (overall: 99.14% vs. 97.91%), and higher positive predictive value (PPV) compared with CE-CT (overall: 57.54% vs. 33.59%) across all surveillance rounds.

CONCLUSION: HBP-AMRI with a 5-minute streamlined workflow substantially outperforms CE-CT in lesion detection rate and patient-level diagnostic performance of CRLMs. HBP-AMRI can provide an efficient and safe alternative modality with longitudinal reliability for postoperative surveillance of CRLM in colorectal cancer patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Xu Q, Shi F, Wang L, et al. Intra-individual comparison of abbreviated gadoxetic acid-enhanced MRI and contrast-enhanced CT for postoperative surveillance of colorectal liver metastases: a multicenter prospective study. Abdom Radiol (NY). 2025. PMID: 41186717. doi:10.1007/s00261-025-05276-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。